Developer docs
API playgroundTry for free, no card

Search company profiles

Gestalt Diagnostics

Full company profile

uuid0000669

Namestring
Gestalt Diagnostics
Legal namestring
Gestalt Diagnostics
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Gestalt Diagnostics, founded in 2017 and headquartered in Spokane, Washington, is an AI-powered digital pathology platform company serving academic medical centers, integrated health networks, reference laboratories, and private pathology groups. The company operates a cloud-based, vendor-neutral platform architecture anchored by PathFlow, which unifies whole slide image viewing, case management, and patient data in a single environment with configurable Anatomic Pathology, Education, and Research modules. Supporting products include PathCloud for web-based image sharing and collaboration, Health Data Cloud for healthcare data interoperability, Electronic Lab Reporting for public health submissions, and LIS migration and IT staff augmentation services. Gestalt's AI capabilities are delivered through an open AI Portfolio that integrates third-party and custom AI applications into the diagnostic workflow, with validated interoperability across 8 of 9 major WSI scanner brands and multiple AI Evidence Creators demonstrated at the 2025 DICOM WG-26 Connectathon.

The company makes money primarily through enterprise subscription licensing of the PathFlow platform, supplemented by professional services revenue from implementation, LIS migration, custom AI development, and ongoing IT support. Pricing is not publicly disclosed and follows a quote-based consultative sales motion targeting enterprise buyers, with a 'Request a Demo' primary call-to-action and white-glove onboarding. Gestalt sells through a direct enterprise field sales force complemented by channel partnerships including DLS for international markets and Voicebrook for joint go-to-market with speech-enabled reporting. The customer base spans 25+ named organizations across enterprise and mid-market tiers, including Johns Hopkins Medicine, NYU Langone Health, UCLA Health, Stanford Medicine, ARUP Laboratories, BioReference Laboratories, Moffitt Cancer Center, Baylor Scott & White Health, Northwell Health, and Baptist Health South Florida.

In April 2025, Gestalt closed a $7.5 million Series A round led by Cowles Ventures and TVF Funds, with capital directed toward AI capability enhancement, FDA clearance pursuits, and customer base expansion. The company maintains HIPAA, SOC 2 Type II, and CE-IVD certifications, holds registered trademarks for PathFlow and PathCloud, and has strategic partnerships with Optum (UnitedHealth Group), Voicebrook, Primaa, AIRA Matrix, OmniPathology, and Leica Biosystems. Recent product milestones include PathFlow Version 6 (October 2025), the Voicebrook speech-enabled integration (September 2025), and the first African client onboarding (DataPathology, March 2025).

Short descriptiontext

Gestalt Diagnostics is a Spokane-based digital pathology company that provides a cloud-based, vendor-neutral platform (PathFlow) unifying whole slide imaging, case management, and AI integration for academic medical centers, reference labs, and pathology groups. It sells via enterprise subscriptions, professional services, and channel partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSpokane, United States
HQ citystring
Spokane
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital pathology software, whole slide imaging, pathology workflow platform, AI pathology solutions, clinical image management
Industry4 codes
PRIMARYHLACAMAB
Anatomic Pathology LIS & Digital Pathology Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Digital Pathology Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Software Platform Subscription
TypeSubscription Recurring
Description

Subscription-based access to PathFlow and PathCloud digital pathology platforms. Likely tiered based on modules, users, or volume.

gestaltdiagnostics.com
2Professional Services
TypeProfessional Services
Description

Implementation, onboarding, training, and ongoing support services. Includes staff augmentation for healthcare IT teams.

gestaltdiagnostics.com
3AI Solutions
TypeSubscription Recurring
Description

AI Portfolio and custom AI solutions integrated into the platform, likely bundled or add-on to core subscription.

gestaltdiagnostics.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1PathFlow®
Description

Digital pathology platform that unifies image, case, and patient management in a single, automated environment for pathologists.

gestaltdiagnostics.com
+2 more records
Core offering1 text field

Gestalt Diagnostics sells a cloud-based enterprise digital pathology platform called PathFlow that unifies whole slide image viewing, case management, and patient data for anatomic pathology, education, and research workflows. The offering is complemented by PathCloud for web-based image sharing, Health Data Cloud for interoperability with EHR/LIS systems, Electronic Lab Reporting, AI Portfolio (open AI infrastructure), AI Custom Solutions, and IT services such as LIS migration and outsourced support. Customers are primarily healthcare systems, academic medical centers, and private pathology laboratories.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Integrated automation has enabled some labs to reduce manual steps by approximately 75%
+2 more records
Product overview1 text field

Gestalt Diagnostics offers a unified digital pathology platform architecture centered on PathFlow®, a cloud-based enterprise digital pathology system with modular components. The platform consists of three integrated modules—Anatomic Pathology (clinical diagnostic), Education, and Research—providing flexibility for facilities to mix and match based on their operational needs. Supporting the core platform are complementary products including PathCloud® for web-based image sharing and collaboration, Health Data Cloud for healthcare interoperability, and Electronic Lab Reporting (ELR) for public health compliance. AI capabilities are delivered through the AI Portfolio (open infrastructure for third-party AI integration) and AI Custom Solutions (custom development services). IT services including LIS Migration, Outsource LIS Support, and Healthcare IT Staff Augmentation support implementation and ongoing operations. The platform is vendor-neutral, integrating with Epic and Cerner EHR systems, WSI scanners from multiple manufacturers, and AI annotation tools from vendors like Visiopharm, Hologic, TechCyte, and identify.bio.

Product and service9 records
1PathFlow
CategoryDigital Pathology Platform
Description

PathFlow is Gestalt's primary cloud-based digital pathology platform that unifies image, case, and patient management in a single automated environment for pathology laboratories, with configurable workflows supporting Anatomic Pathology, Education, and Research modules. It is designed for health systems, academic medical centers, reference laboratories, and hospital labs.

2PathCloud
CategoryDigital Pathology Platform
Description

PathCloud is a secure, web-based interface for digital image sharing and collaboration that helps organizations adopt digital pathology without heavy infrastructure investment or workflow disruption. It is intended for pathologists and labs needing lightweight, browser-based access to whole slide images.

3Health Data Cloud
CategoryHealthcare Interoperability Software
Description

Health Data Cloud is a healthcare-compliant, web-based interface engine that connects healthcare applications and reporting agencies, enabling reliable, standards-based data exchange across healthcare IT systems. It targets healthcare organizations requiring interoperability between LIS, EHR, and reporting systems.

4Electronic Lab Reporting (ELR)
CategoryPublic Health Reporting Software
Description

Electronic Lab Reporting (ELR) is an automated laboratory reporting service for reportable diseases and cancer reporting to public health and regulatory agencies, ensuring timely, validated data submission. It is used by hospital and reference laboratories with public health compliance obligations.

5LIS Migration
CategoryHealthcare IT Professional Services
Description

LIS Migration is an end-to-end laboratory information system migration service that manages patient, case, and workflow data transitions with minimal downtime while preserving existing integrations. It is targeted at laboratories transitioning between LIS platforms or consolidating multi-LIS environments.

6Outsourced LIS Support Services
CategoryHealthcare IT Professional Services
Description

Outsourced LIS Support Services provide expert ongoing LIS support that maintains system stability, resolves issues quickly, and extends existing LIS investments without adding internal IT strain. It targets hospital and reference laboratories seeking external operational support for their LIS.

7Healthcare IT Staff Augmentation
CategoryHealthcare IT Professional Services
Description

Healthcare IT Staff Augmentation provides flexible staffing of experienced healthcare IT professionals to augment internal teams for integrations, implementations, and modernization initiatives. It targets healthcare organizations needing surge IT capacity for digital pathology and LIS projects.

8AI Portfolio
CategoryAI Integration Software
Description

AI Portfolio is an open AI infrastructure that integrates clinically validated AI applications directly into the PathFlow workflow, supporting third-party AI tools and enabling pathologist choice, control, and clinical workflow alignment. It is intended for pathology groups that want access to multiple AI algorithms within a single viewer environment.

9AI Custom Solutions
CategoryAI Professional Services
Description

AI Custom Solutions is a custom AI development service that enables organizations to build tailored AI solutions integrated into PathFlow for specific diagnostic and operational needs. It targets pathology groups, health systems, and research institutions with specialized AI requirements that off-the-shelf tools cannot meet.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1OmniPathology
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

October 2025 partnership where OmniPathology selected Gestalt's PathFlow as their digital platform and strategic partner. Focus on precision, scalability, interoperability, and global diagnostic equity with initiatives to extend digital diagnostics to underserved regions.

prnewswire.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-01
Description

September 2025 announcement of seamless integration between Voicebrook's VoiceOver PRO reporting platform and Gestalt's PathFlow. Industry's first fully speech-enabled digital pathology solution enabling pathologists to control image navigation and report creation by voice.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-01
Description

March 2025 partnership to advance AI-powered skin cancer detection through integrated digital pathology solutions. Collaboration focuses on dermatopathology tools combining Primaa's AI capabilities with Gestalt's PathFlow platform.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-03-01
Description

March 2025 partnership to elevate diagnostics with AI-driven QC platform. Integrates AIRA Matrix's quality control AI capabilities into Gestalt's digital pathology workflow.

Strategic tierStrategicTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-03-01
Description

March 2025 reseller agreement enabling global expansion. DLS serves as reseller for Gestalt's digital pathology solutions in international markets.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-01
Description

November 2024 partnership adding Gestalt to Optum's Digital Diagnostic Suite. Strategic integration of Gestalt's digital pathology capabilities into Optum's healthcare ecosystem.

Strategic tierStrategicTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-09-01
Description

First client in Africa - DataPathology represents Gestalt's international expansion into African markets.

Strategic tierStrategicTypeTechnology or Integration
Description

Hardware partnership referenced in customer context. BioReference Laboratories paired Leica's hardware system with Gestalt's pathology workflow platform for innovative digital workflow.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Proscia is a digital pathology platform company offering Concentriq, an enterprise pathology workflow platform with AI integration and multi-WSI-scanner support, directly competing with Gestalt's PathFlow for academic medical centers, reference labs, and IDN contracts.

TypeDirect peer
Description

PathAI provides AI-powered pathology solutions and a digital pathology workflow platform (AISight), serving biopharma, academic centers, and clinical labs with integrated AI diagnostics and image management - closely aligned with Gestalt's platform-plus-AI offering.

TypeDirect peer
Description

Ibex develops AI-powered cancer diagnostics deployed within pathology workflows, with both standalone AI algorithms and an integrated pathology platform - a direct competitor to Gestalt's AI Portfolio and PathFlow strategy.

TypeDirect peer
Description

Indica Labs provides Halo and HALO AP digital pathology software for image analysis, AI integration, and pathology workflow - competing with Gestalt in anatomic pathology image management and AI deployment.

TypeDirect peer
Description

Visiopharm offers AI-driven pathology image analysis and workflow software (Phenoptics, Oncotopix), and is integrated with Gestalt via the DICOM WG-26 Connectathon as an AI Evidence Creator - a peer in AI pathology and a partner/competitor on the algorithm side.

TypeEmerging player
Description

Owkin applies AI to pathology and other clinical data, with both biopharma services and emerging clinical pathology offerings - an emerging peer in AI-enabled diagnostics with partial overlap to Gestalt's AI Portfolio direction.

TypeBroad incumbent
Description

Philips offers IntelliSite Pathology Solution with enterprise WSI scanners and image management software - a broad incumbent whose bundled hardware/software offering competes with Gestalt's vendor-neutral platform, particularly in large IDN deployments.

TypeBroad incumbent
Description

Roche's Ventana Digital Pathology platform combines slide scanners, image management software, and AI algorithms (including partnerships with PathAI) - a broad incumbent and one of the most formidable competitors to standalone digital pathology vendors.

TypeBroad incumbent
Description

Leica Biosystems offers Aperio digital pathology scanners and enterprise image management, with hardware integration partnerships across the industry - a broad incumbent whose hardware footprint shapes the market in which Gestalt's vendor-neutral software competes.

TypeEmerging player
Description

AIRA Matrix provides AI solutions for pathology and life sciences, including the AI-driven quality control platform that Gestalt integrated in March 2025 - both an emerging AI pathology peer and a tactical technology partner.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers25 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration12 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gestalt Diagnostics

Digital Pathology Softwaregestaltdiagnostics.com

Gestalt Diagnostics is a Spokane-based digital pathology company that provides a cloud-based, vendor-neutral platform (PathFlow) unifying whole slide imaging, case management, and AI integration for academic medical centers, reference labs, and pathology groups. It sells via enterprise subscriptions, professional services, and channel partners.

What Gestalt Diagnostics does

Gestalt Diagnostics, founded in 2017 and headquartered in Spokane, Washington, is an AI-powered digital pathology platform company serving academic medical centers, integrated health networks, reference laboratories, and private pathology groups. The company operates a cloud-based, vendor-neutral platform architecture anchored by PathFlow, which unifies whole slide image viewing, case management, and patient data in a single environment with configurable Anatomic Pathology, Education, and Research modules. Supporting products include PathCloud for web-based image sharing and collaboration, Health Data Cloud for healthcare data interoperability, Electronic Lab Reporting for public health submissions, and LIS migration and IT staff augmentation services. Gestalt's AI capabilities are delivered through an open AI Portfolio that integrates third-party and custom AI applications into the diagnostic workflow, with validated interoperability across 8 of 9 major WSI scanner brands and multiple AI Evidence Creators demonstrated at the 2025 DICOM WG-26 Connectathon.

The company makes money primarily through enterprise subscription licensing of the PathFlow platform, supplemented by professional services revenue from implementation, LIS migration, custom AI development, and ongoing IT support. Pricing is not publicly disclosed and follows a quote-based consultative sales motion targeting enterprise buyers, with a 'Request a Demo' primary call-to-action and white-glove onboarding. Gestalt sells through a direct enterprise field sales force complemented by channel partnerships including DLS for international markets and Voicebrook for joint go-to-market with speech-enabled reporting. The customer base spans 25+ named organizations across enterprise and mid-market tiers, including Johns Hopkins Medicine, NYU Langone Health, UCLA Health, Stanford Medicine, ARUP Laboratories, BioReference Laboratories, Moffitt Cancer Center, Baylor Scott & White Health, Northwell Health, and Baptist Health South Florida.

In April 2025, Gestalt closed a $7.5 million Series A round led by Cowles Ventures and TVF Funds, with capital directed toward AI capability enhancement, FDA clearance pursuits, and customer base expansion. The company maintains HIPAA, SOC 2 Type II, and CE-IVD certifications, holds registered trademarks for PathFlow and PathCloud, and has strategic partnerships with Optum (UnitedHealth Group), Voicebrook, Primaa, AIRA Matrix, OmniPathology, and Leica Biosystems. Recent product milestones include PathFlow Version 6 (October 2025), the Voicebrook speech-enabled integration (September 2025), and the first African client onboarding (DataPathology, March 2025).

Gestalt Diagnostics firmographics

Firmographics
Name
Gestalt Diagnostics
Legal name
Gestalt Diagnostics
Website
https://gestaltdiagnostics.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Gestalt Diagnostics is a Spokane-based digital pathology company that provides a cloud-based, vendor-neutral platform (PathFlow) unifying whole slide imaging, case management, and AI integration for academic medical centers, reference labs, and pathology groups. It sells via enterprise subscriptions, professional services, and channel partners.
Ownership category
akta.pro rank

Gestalt Diagnostics industry classification

Industry
Product category
Digital Pathology Software
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAMAB
Anatomic Pathology LIS & Digital Pathology Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Digital pathology software
  • Whole slide imaging
  • Pathology workflow platform
  • AI pathology solutions
  • Clinical image management

Where Gestalt Diagnostics is headquartered

Location

Headquarters

HQ city
Spokane
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Gestalt Diagnostics business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Software Platform Subscription: Subscription-based access to PathFlow and PathCloud digital pathology platforms. Likely tiered based on modules, users, or volume.
  2. Professional Services: Implementation, onboarding, training, and ongoing support services. Includes staff augmentation for healthcare IT teams.
  3. AI Solutions: AI Portfolio and custom AI solutions integrated into the platform, likely bundled or add-on to core subscription.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Gestalt Diagnostics product offering

Product offering

Core offering

Gestalt Diagnostics sells a cloud-based enterprise digital pathology platform called PathFlow that unifies whole slide image viewing, case management, and patient data for anatomic pathology, education, and research workflows. The offering is complemented by PathCloud for web-based image sharing, Health Data Cloud for interoperability with EHR/LIS systems, Electronic Lab Reporting, AI Portfolio (open AI infrastructure), AI Custom Solutions, and IT services such as LIS migration and outsourced support. Customers are primarily healthcare systems, academic medical centers, and private pathology laboratories.

Product overview

Gestalt Diagnostics offers a unified digital pathology platform architecture centered on PathFlow®, a cloud-based enterprise digital pathology system with modular components. The platform consists of three integrated modules—Anatomic Pathology (clinical diagnostic), Education, and Research—providing flexibility for facilities to mix and match based on their operational needs. Supporting the core platform are complementary products including PathCloud® for web-based image sharing and collaboration, Health Data Cloud for healthcare interoperability, and Electronic Lab Reporting (ELR) for public health compliance. AI capabilities are delivered through the AI Portfolio (open infrastructure for third-party AI integration) and AI Custom Solutions (custom development services). IT services including LIS Migration, Outsource LIS Support, and Healthcare IT Staff Augmentation support implementation and ongoing operations. The platform is vendor-neutral, integrating with Epic and Cerner EHR systems, WSI scanners from multiple manufacturers, and AI annotation tools from vendors like Visiopharm, Hologic, TechCyte, and identify.bio.

Differentiator

Problem solved

Functional benefit

Brands

  • PathFlow®: Digital pathology platform that unifies image, case, and patient management in a single, automated environment for pathologists.
  • PathCloud®
  • Health Data Cloud

Products and services

  • PathFlow PathFlow is Gestalt's primary cloud-based digital pathology platform that unifies image, case, and patient management in a single automated environment for pathology laboratories, with configurable workflows supporting Anatomic Pathology, Education, and Research modules. It is designed for health systems, academic medical centers, reference laboratories, and hospital labs.
  • PathCloud PathCloud is a secure, web-based interface for digital image sharing and collaboration that helps organizations adopt digital pathology without heavy infrastructure investment or workflow disruption. It is intended for pathologists and labs needing lightweight, browser-based access to whole slide images.
  • Health Data Cloud Health Data Cloud is a healthcare-compliant, web-based interface engine that connects healthcare applications and reporting agencies, enabling reliable, standards-based data exchange across healthcare IT systems. It targets healthcare organizations requiring interoperability between LIS, EHR, and reporting systems.
  • Electronic Lab Reporting (ELR) Electronic Lab Reporting (ELR) is an automated laboratory reporting service for reportable diseases and cancer reporting to public health and regulatory agencies, ensuring timely, validated data submission. It is used by hospital and reference laboratories with public health compliance obligations.
  • LIS Migration LIS Migration is an end-to-end laboratory information system migration service that manages patient, case, and workflow data transitions with minimal downtime while preserving existing integrations. It is targeted at laboratories transitioning between LIS platforms or consolidating multi-LIS environments.
  • Outsourced LIS Support Services Outsourced LIS Support Services provide expert ongoing LIS support that maintains system stability, resolves issues quickly, and extends existing LIS investments without adding internal IT strain. It targets hospital and reference laboratories seeking external operational support for their LIS.
  • Healthcare IT Staff Augmentation Healthcare IT Staff Augmentation provides flexible staffing of experienced healthcare IT professionals to augment internal teams for integrations, implementations, and modernization initiatives. It targets healthcare organizations needing surge IT capacity for digital pathology and LIS projects.
  • AI Portfolio AI Portfolio is an open AI infrastructure that integrates clinically validated AI applications directly into the PathFlow workflow, supporting third-party AI tools and enabling pathologist choice, control, and clinical workflow alignment. It is intended for pathology groups that want access to multiple AI algorithms within a single viewer environment.
  • AI Custom Solutions AI Custom Solutions is a custom AI development service that enables organizations to build tailored AI solutions integrated into PathFlow for specific diagnostic and operational needs. It targets pathology groups, health systems, and research institutions with specialized AI requirements that off-the-shelf tools cannot meet.

Quantifiable outcome

  • Integrated automation has enabled some labs to reduce manual steps by approximately 75%
  • +2 more outcomes

Companies that use Gestalt Diagnostics

Customer profile

Named customers25 records

Segments6 records

Ideal customer profiles5 records

Gestalt Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration12 records

AI capability8 records

Feature8 records

Gestalt Diagnostics partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and strategic.

  • OmniPathologycoreStrategic or Co-development Partner · 1 October 2025October 2025 partnership where OmniPathology selected Gestalt's PathFlow as their digital platform and strategic partner. Focus on precision, scalability, interoperability, and global diagnostic equity with initiatives to extend digital diagnostics to underserved regions.
  • VoicebrookcoreTechnology or Integration · 1 September 2025September 2025 announcement of seamless integration between Voicebrook's VoiceOver PRO reporting platform and Gestalt's PathFlow. Industry's first fully speech-enabled digital pathology solution enabling pathologists to control image navigation and report creation by voice.
  • PrimaacoreStrategic or Co-development Partner · 1 March 2025March 2025 partnership to advance AI-powered skin cancer detection through integrated digital pathology solutions. Collaboration focuses on dermatopathology tools combining Primaa's AI capabilities with Gestalt's PathFlow platform.
  • AIRA MatrixcoreTechnology or Integration · 1 March 2025March 2025 partnership to elevate diagnostics with AI-driven QC platform. Integrates AIRA Matrix's quality control AI capabilities into Gestalt's digital pathology workflow.
  • DLS (DataLink Solutions)strategicChannel Partner/ Reseller/ Distributor · 1 March 2025March 2025 reseller agreement enabling global expansion. DLS serves as reseller for Gestalt's digital pathology solutions in international markets.
  • Optum (UnitedHealth Group)coreStrategic or Co-development Partner · 1 November 2024November 2024 partnership adding Gestalt to Optum's Digital Diagnostic Suite. Strategic integration of Gestalt's digital pathology capabilities into Optum's healthcare ecosystem.
  • DataPathologystrategicChannel Partner/ Reseller/ Distributor · 1 September 2024First client in Africa - DataPathology represents Gestalt's international expansion into African markets.
  • Leica BiosystemsstrategicTechnology or IntegrationHardware partnership referenced in customer context. BioReference Laboratories paired Leica's hardware system with Gestalt's pathology workflow platform for innovative digital workflow.

Scale indicators5 records

Recent moves6 records

Expansion highlights7 records

Gestalt Diagnostics competitors and assessment

Company assessment

Direct peers

  • Proscia: Proscia is a digital pathology platform company offering Concentriq, an enterprise pathology workflow platform with AI integration and multi-WSI-scanner support, directly competing with Gestalt's PathFlow for academic medical centers, reference labs, and IDN contracts.
  • PathAI: PathAI provides AI-powered pathology solutions and a digital pathology workflow platform (AISight), serving biopharma, academic centers, and clinical labs with integrated AI diagnostics and image management - closely aligned with Gestalt's platform-plus-AI offering.
  • Ibex Medical Analytics: Ibex develops AI-powered cancer diagnostics deployed within pathology workflows, with both standalone AI algorithms and an integrated pathology platform - a direct competitor to Gestalt's AI Portfolio and PathFlow strategy.
  • Indica Labs: Indica Labs provides Halo and HALO AP digital pathology software for image analysis, AI integration, and pathology workflow - competing with Gestalt in anatomic pathology image management and AI deployment.
  • Visiopharm: Visiopharm offers AI-driven pathology image analysis and workflow software (Phenoptics, Oncotopix), and is integrated with Gestalt via the DICOM WG-26 Connectathon as an AI Evidence Creator - a peer in AI pathology and a partner/competitor on the algorithm side.

Emerging players

  • Owkin: Owkin applies AI to pathology and other clinical data, with both biopharma services and emerging clinical pathology offerings - an emerging peer in AI-enabled diagnostics with partial overlap to Gestalt's AI Portfolio direction.
  • AIRA Matrix: AIRA Matrix provides AI solutions for pathology and life sciences, including the AI-driven quality control platform that Gestalt integrated in March 2025 - both an emerging AI pathology peer and a tactical technology partner.

Broad incumbents

  • Philips Digital Pathology: Philips offers IntelliSite Pathology Solution with enterprise WSI scanners and image management software - a broad incumbent whose bundled hardware/software offering competes with Gestalt's vendor-neutral platform, particularly in large IDN deployments.
  • Roche (Ventana): Roche's Ventana Digital Pathology platform combines slide scanners, image management software, and AI algorithms (including partnerships with PathAI) - a broad incumbent and one of the most formidable competitors to standalone digital pathology vendors.
  • Leica Biosystems: Leica Biosystems offers Aperio digital pathology scanners and enterprise image management, with hardware integration partnerships across the industry - a broad incumbent whose hardware footprint shapes the market in which Gestalt's vendor-neutral software competes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Gestalt Diagnostics social profiles

Digital presence

Gestalt Diagnostics compliance and trust

Trust signal

Compliance4 records

Gestalt Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gestalt Diagnostics leadership team

Management profile

Number of profiles

Profiles5 records

Gestalt Diagnostics funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gestalt Diagnostics M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gestalt Diagnostics

What does Gestalt Diagnostics do?

Gestalt Diagnostics sells a cloud-based enterprise digital pathology platform called PathFlow that unifies whole slide image viewing, case management, and patient data for anatomic pathology, education, and research workflows. The offering is complemented by PathCloud for web-based image sharing, Health Data Cloud for interoperability with EHR/LIS systems, Electronic Lab Reporting, AI Portfolio (open AI infrastructure), AI Custom Solutions, and IT services such as LIS migration and outsourced support. Customers are primarily healthcare systems, academic medical centers, and private pathology laboratories.

Is Gestalt Diagnostics a public or private company?

Gestalt Diagnostics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Gestalt Diagnostics founded?

Gestalt Diagnostics was founded in 2017. It employs 11 to 50 people.

Where is Gestalt Diagnostics based?

Gestalt Diagnostics is headquartered in Spokane, United States, in the North America region.

How does Gestalt Diagnostics make money?

Three revenue lines are on record. Software Platform Subscription is the primary driver. The others are professional Services and AI Solutions.

Who are Gestalt Diagnostics's main competitors?

Direct peers on record are Proscia, PathAI, Ibex Medical Analytics, Indica Labs and Visiopharm. Emerging players are Owkin and AIRA Matrix. Broad incumbents are Philips Digital Pathology, Roche (Ventana) and Leica Biosystems.

Does Gestalt Diagnostics have an API?

No public API is recorded for Gestalt Diagnostics.

What industry is Gestalt Diagnostics in?

Gestalt Diagnostics's product category is Digital Pathology Software. Its primary akta.pro industry code is HLACAMAB, Anatomic Pathology LIS & Digital Pathology Workflow, with a secondary code of HLACABAM, Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comSkin Cancer Diagnostics Market Trends Support A 8.6% CAGR Outlook Through The Forecast PeriodThe skin cancer diagnostics market is projected to reach $5.09 billion by 2030, growing at an 8.6% CAGR. Growth is driven by AI and molecular diagnostics, with a March 2025 partnership between Gestalt Diagnostics and Primaa to enhance skin cancer detection.SpokanejournalFour INW companies make Inc. magazine's fastest growing listFour Inland Northwest-based companies made Inc. magazine's annual list of the 5,000 fastest-growing U.S. firms. Quiroga Law ranked No. 1,735 with 201% revenue growth, while Elevated Estate Planning, Spiceology, and Gestalt Diagnostics also appeared with 74%, 70%, and 65% growth respectively.Clinical Lab ProductsLabs Say They’re Automated. The Workflow Tells a Different StoryA new industry analysis finds that many laboratories consider themselves automated but still rely on significant manual processes, including manual data entry, paper requisitions, and manual result review before release. Experts from LigoLab, Siemens Healthineers, and Gestalt Diagnostics identify pre-analytical and post-analytical phases—particularly specimen accessioning, physician communication, and billing—as the primary gaps where automation efforts fall short. The article notes that while integrated automation has enabled some labs to reduce manual steps by approximately 75% and absorb volume increases without adding staff, persistent integration issues between systems like LIS, billing, and EHR continue to create manual workarounds.openPR.comEmerging Sub-Segments Transforming the Skin Cancer Diagnostics Market LandscapeThe skin cancer diagnostics market is projected to grow to $5.09 billion by 2030 at a compound annual growth rate of 8.6%, driven by AI adoption, advanced imaging, and teledermatology services. In March 2025, Gestalt Diagnostics partnered with Primaa to advance AI-powered skin cancer detection through integrated digital pathology solutions. Additionally, Skin Check Champions, in collaboration with the University of South Australia and The Hospital Research Foundation, launched an AI-powered pop-up clinic in January 2023 to improve skin cancer diagnosis access in Australia.PR NewswireIndiana Animal Disease Diagnostic Laboratory (ADDL) Selects Gestalt Diagnostics' PathFlow® to Advance Digital Pathology InnovationThe Indiana Animal Disease Diagnostic Laboratory (ADDL) at Purdue University has selected Gestalt Diagnostics' PathFlow® digital pathology platform to support its clinical, educational, and research initiatives. The laboratory aims to streamline workflows, enhance collaboration, and integrate AI tools for diagnostics through the deployment beginning with the AP (clinical) module. The partnership may expand to educational and research workflows, including AI development and integration, according to statements from both organizations.YahooTulsa Medical Laboratory Partners with Gestalt Diagnostics to Drive Digital Pathology InnovationTulsa Medical Lab selected Gestalt Diagnostics' PathFlow as its digital pathology solution to unify diagnostic processes across multiple systems. The partnership provides integrated AI tools to support efficiency and accuracy, with the lab aiming for a one-stop digital system. TML's long-term goal is a unified, pathologist-centered digital environment.GestaltdiagnosticsGestalt in the Press and out in the IndustryGestalt Diagnostics announced the release of PathFlow Version 6, a digital pathology platform update featuring an enhanced field of view and a dedicated tumor board workflow module. The company also secured partnerships with Tulsa Medical Laboratory and OmniPathology to implement its AI-driven solutions for streamlined diagnostic operations and global health initiatives.PR NewswireTulsa Medical Laboratory Partners with Gestalt Diagnostics to Drive Digital Pathology InnovationGestalt has partnered with Tulsa Medical Laboratory (TML) to provide its PathFlow digital pathology solution, supporting TML's strategy to enhance diagnostic accuracy and AI adoption. The collaboration aims to unify TML's diagnostic processes and enable better workflow efficiency with integrated AI tools.Clinical Lab ProductsGestalt's Digital Pathology Platform Selected by Oklahoma LaboratoryTulsa Medical Lab has selected Gestalt Diagnostics' PathFlow digital pathology platform to unify its diagnostic processes across multiple laboratory information systems, allowing pathologists to access all cases through a single login and consolidated worklist. The implementation includes integrated AI tools designed to enhance diagnostic efficiency and accuracy, representing Tulsa Medical Lab's move toward a fully digital workflow. Gestalt Diagnostics, based in Spokane, Washington, will provide the scalable solution as part of the lab's long-term goal to establish a foundation for future AI-enabled diagnostic processes.